IBS and antidepressants: what the MCSC study showed
NewsWhy does IBS remain one of the most difficult mysteries of gastroenterology?
Irritable bowel syndrome is the most common functional disease of the gastrointestinal tract, which affects up to 50% of adults worldwide. The reasons may be both in the work of the intestine and in the peculiarities of the nervous system — therefore, it must be treated comprehensively.
In a new article, experts of the MCSC named after A.S. Loginov analyze modern ideas about IBS and the effectiveness of antidepressants in the treatment of severe forms.
Read the material in the "Current topic" section from NIIOZMM at the link.
The article presents the results of a study conducted on the basis of the MCSC Laboratory of Functional Diagnostics of intestinal diseases, where they evaluated how antidepressants help patients with severe IBS-D. The authors have shown that such drugs can not only reduce pain and normalize stool, but also improve the general well-being and quality of life of patients.
